For the purpose of promoting the USGENE® in-house version more effectively in Europe, US-based SequenceBase Corporation and FIZ Karlsruhe have entered into an agreement according to which FIZ Karlsruhe will act as a sales agent on behalf of the SequenceBase Corporation.
In this capacity, FIZ Karlsruhe will sell and market the USGENE® database in-house version to customers and prospective customers of the SequenceBase Corporation in enterprises and institutes throughout Europe. USGENE® is also available via FIZ Karlsruhe's leading online-service STN InternationalSM. Both offerings complement each other, but target different user groups.
Scientists working in drug discovery operations, academia, and life sciences may now benefit from the customized in-house version of SequenceBase Corporation's prestigious USGENE® database. USGENE® is the ground-breaking resource for life-science intellectual property professionals, providing unrivalled searchable access to all available peptide and nucleotide sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO). It is the unparalleled resource in which to perform freedom-to-operate, prior art, validity, infringement and competitive intelligence patent sequence searches within United States gene patent publications.
USGENE® data are available in customized subscription formats to suit various in-house molecular biology patent information needs. The database can be implemented and integrated in other life science products such as Laboratory Information Management Systems (LIMS), Drug Discovery Platforms, Patent Portals, Web Host interfaces and other online information services. USGENE® data can be provided in industry standard or customized data formats to suit particular in-house needs.
According to the customers' needs, the USGENE® database can be purchased by segments of data such as class, art unit, patent assignee, inventor, publication date, or any other desired fields. The entire back file from 1982 to date can be licensed; regular weekly updates are provided to subscribers within 3 days of publication by the United States Patent Office.
An agreement between SequenceBase Corp. and FIZ Karlsruhe with respect to the offering of USGENE® via the online-service STN International has been existing since 2006. The unique combination of prestigious STN® patent sequence databases DGENE (GENESEQTM), PCTGEN, REGISTRYSM and USGENE® gives life-science intellectual property professionals the ability to make business critical decisions with much greater certainty.
"We are pleased with this opportunity to deepen our partnership with SequenceBase Corporation which has already proven successful with our joint offering of USGENE® on STN® ", said Sabine Brünger-Weilandt, President and CEO of FIZ Karlsruhe. "Both partners now desire to further collaborate for the purpose of promoting the USGENE® database more effectively in Europe in order to attract new customer groups." Rainer Stuike-Prill, Vice-President Marketing & Sales at FIZ Karlsruhe stated: "We are convinced that FIZ Karlsruhe's long-standing experience in providing information services and customer support will make this new project a success and fully satisfy our customers' demands for first-class information and excellent service."
"Once again, we are delighted to partner with FIZ Karlsruhe, in this new alliance", commented Martin Goffman, President and CEO of the SequenceBase Corporation. "This agreement will strengthen our position in Europe while at the same time providing exceptional local service to our European subscribers".
For further information, please contact:Martin Goffman
To learn more about SequenceBase products and services, email us at email@example.com.
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Earth Sciences
05.12.2016 | Physics and Astronomy
05.12.2016 | Life Sciences